NEW YORK--(BUSINESS WIRE)--H1, a New York-based healthcare AI data-driven solutions provider, today announced its acceptance to Y Combinator’s (YC) Winter 2020 batch of portfolio companies. H1 joins the ranks of YC’s illustrious portfolio of companies including Airbnb, Dropbox, Stripe, Reddit, Doordash, Coinbase, Twitch and others. This announcement comes as H1 opens its first San Francisco location.
Joining this network of the world’s top startups, and expanding the company’s operations in San Francisco, validates H1’s commitment to expansion of its global healthcare analytics platforms. Last year, the company grew its impressive customer base to more than 35 pharma clients, with record revenue growth by 350% in the last year.
“We are super excited about joining YC, as this one in a lifetime opportunity will offer invaluable mentorship and collaboration with fellow YC companies and alumni. Our team will also benefit from extensive access to YC’s network of investors, mentors and partners, as we continue our growth and expansion in the US and globally,” said Ariel Katz, Co- Founder, H1. “Pharma and biotech companies are using H1 to accelerate drug development with our AI-driven healthcare dataset. Our main product will continue to be the premium solution for medical affairs and marketing teams in the life sciences.”
H1’s product suite uses the latest in data science and subject matter experts to produce proprietary data intelligence products for healthcare and life sciences companies. Over 8 million healthcare professional (HCP) profiles are kept up to date every week, and more than 16,000 institutions are profiled. There is coverage across 800 different specialties and the most prevalent therapeutic indications. This is the first time this many HCP profiles has been aggregated and kept up to date. Instead of users going to LinkedIn before a meeting with a HCP, they now go to H1.
H1 was built by scientists for scientists. We empower stakeholders at healthcare and life science companies to make smarter decisions using data. Working with some of the largest and most influential global life science organizations, H1 provides insight into thought leaders, scholarly content, academics, and healthcare professionals. For more information on H1, please visit https://h1insights.com.